'Benign' vein issue behind Trump's swollen legs: White House
The presidential physician found Trump, 79, has "chronic venous insufficiency" -- a condition where damaged leg veins fail to keep blood flowing properly -- Press Secretary Karoline Leavitt told reporters, calling it a "benign and common condition."
Responding to speculation over recent photos showing bruising on Trump's hand, Leavitt said "this was consistent with minor soft tissue irritation from frequent handshaking and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen."
Trump became the oldest person in history to assume the presidency when he began his second term this January, replacing Democrat Joe Biden, who stepped down at 81.
The Republican frequently boasts of his energy levels and the administration recently even posted an image depicting him as Superman.
In April, Trump said after undergoing a routine medical check-up that he was in "very good shape."
Leavitt's revelations follow viral online discussions about the president's visibly swollen ankles and discolored right hand.
She said he had undergone "a comprehensive examination, including diagnostic vascular studies. Bilateral lower extremity venous doppler ultrasounds were performed and revealed chronic venous insufficiency, a benign and common condition, particularly in individuals over the age of 70."
"Importantly, there was no evidence of deep vein thrombosis or arterial disease," she said.
All Trump's test results "were within normal limits," she said and he had a "normal cardiac structure and function, no signs of heart failure, renal impairment or systemic illness."
The hand issue, she said, was linked to the aspirin he takes in a "standard" cardiovascular health program.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
5 hours ago
- News.com.au
‘World's oldest baby' is born from embryo frozen before either of his parents even started school
The world's 'oldest baby' has been born from an embryo frozen before either of his parents even started school. Thaddeus Daniel Pierce was delivered on July 26 to parents Lindsey and Tim Pierce, of Ohio – over three decades after his embryo was frozen. The tot, who has broken the record for the oldest baby, even has a 30-year-old sister – who is now a mum herself to a 10-year-old girl, The Sun reports. The title was previously held by twins who were created from embryos frozen 30 years before their birth. Lindsay told MIT Technology Review: 'We didn't go into it thinking we would break any records. We just wanted a baby.' Thaddeus's embryo was created along with three others during a course of IVF in the 1990s for Linda Archerd and her then-husband. One of the embryos was implanted into Linda who conceived her now 30-year-old daughter. The remaining embryos were put in long-term storage before being put up for embryo adoption when Linda and her partner separated. Embryo adoptions are more typical in the US – particularly at Christian clinics – to help families struggling to conceive. After seven years trying for a baby, Lindsey and Tim signed up for the same program and were offered Thaddeus's embryo. 'We had a rough birth, but we're both doing well now,' Lindsey said. 'He is so chill. We are in awe that we have this precious baby,' she added. 'Snow babbies' In 2017, a baby girl was born from a 25-year-old embryo in what was then a world first in the US. Little Emma Wren Gibson weighed 6lbs 8oz (about 2.9kg) and measured 20 inches (about 50cm) long when she was born. Her parents, Tina and Benjamin Gibson, said their daughter's record status was their last priority, focusing only on her health, adding they felt 'thankful and blessed' to have her. They said they were surprised when they were told the exact age of the embryo, thawed on March 13 at the National Embryo Donation Center (NEDC). 'Do you realise I'm only 25? This embryo and I could have been best friends,' Tina told CNN. Tina, who was 26 at the time, said she just wanted a baby and didn't care if it was going to be a world record or not. 'We're just so thankful and blessed. She's a precious Christmas gift from the Lord.' Baby Emma was created via IVF for another couple but had been left in storage for someone else. Embryos like this are called 'snow babies' – potential human lives left on ice waiting to be born. Seven years ago Tina and Benjamin got married knowing they would not be able to have biological children as Benjamin has cystic fibrosis. They had fostered several children and were planning on adoption before having the embryo implanted.
News.com.au
6 hours ago
- News.com.au
Lunch Wrap: ASX slips heavily, Novonix scraps graphite spin-out
Banks, tech and health take a dive ResMed surged after smashing earnings The ASX 200 was down by 0.75% at lunch time in the eastern states, with investors firmly in risk-off mode. Only miners and utilities put up a fight. Everywhere else, it was a mess. Health stocks were out of breath, tech looked like it had skipped leg day, and the big banks all sagged under the weight of global tariff fears. It's the kind of day where even the good names get dragged through the mud. Commonwealth Bank (ASX:CBA), National Australia Bank (ASX:NAB), WiseTech Global (ASX:WTC) and Xero (ASX:XRO) all retreated. This all followed another tariff tantrum from Donald Trump. Canada just got hit with a jump from 25% to 35%, and new levies were slapped on Thailand, Cambodia, Taiwan and Switzerland. Australia, somehow, managed to dodge the full swing, for now. But with tariffs pushing up import prices, bets on US rate cuts just got punted out to October. In the large caps space, conglomerate Washington H Soul Pattinson (ASX:SOL) nudged lower despite lifting its dividend again - its 27th annual increase, if you don't mind. Downer EDI (ASX:DOW) bagged a fresh $220 million defence deal, and ResMed (ASX:RMD) surged after smashing earnings expectations with a 37% jump in profit. ResMed reckons it will keep growing even with Ozempic and its weight loss-pill mates nipping at the edges of the sleep apnoea market. Gold producer Bellevue Gold (ASX:BGL) climbed after setting bullish production guidance of up to 150,000 ounces in FY26. Meanwhile, Novonix (ASX:NVX) and Lithium Energy (ASX:LEL) have pulled the plug on the Axon Graphite IPO and the Mt Dromedary deal, citing weak market conditions. Novonix is now reviewing next steps for Mt Dromedary, and its directors have resigned from the Axon board. Shares were flat. ASX SMALL CAP WINNERS Here are the best performing ASX small cap stocks for August 1 : Security Description Last % Volume MktCap CYQ Cycliq Group Ltd 0.005 150% 7,878,960 $921,033 DMG Dragon Mountain Gold 0.013 117% 725,258 $2,368,030 1AE Aurora Energy Metals 0.081 62% 1,792,535 $8,953,187 LNR Lanthanein Resources 0.002 50% 17,675,218 $3,734,001 RLG Roolife Group Ltd 0.004 33% 70,872 $4,778,344 AON Apollo Minerals Ltd 0.009 29% 150,000 $6,499,198 4DX 4Dmedical Limited 0.300 25% 9,364,191 $111,729,714 CTN Catalina Resources 0.005 25% 200,000 $9,704,076 GSM Golden State Mining 0.010 25% 252,061 $2,234,965 MEL Metgasco Ltd 0.003 25% 125,337 $3,674,173 PIL Peppermint Inv Ltd 0.003 25% 200,090 $4,602,180 QXR Qx Resources Limited 0.005 25% 5,200,000 $5,241,315 VRC Volt Resources Ltd 0.005 25% 4,040,000 $18,739,398 LKY Locksleyresources 0.130 24% 26,437,175 $19,250,000 8CO 8Common Limited 0.026 24% 1,176,072 $4,705,993 SPG Spc Global Holdings 0.405 23% 75,363 $63,684,021 IR1 Irismetals 0.110 22% 522,009 $16,016,344 DTM Dart Mining NL 0.003 20% 6,303,558 $2,995,139 RAN Range International 0.003 20% 1,846,960 $2,348,226 GBE Globe Metals &Mining 0.052 18% 685,582 $30,564,732 EXL Elixinol Wellness 0.020 18% 340,750 $3,913,254 STM Sunstone Metals Ltd 0.020 18% 23,846,808 $104,874,083 CCO The Calmer Co Int 0.004 17% 143,000 $9,034,060 CHM Chimeric Therapeutic 0.004 17% 768,284 $9,747,370 HPC Thehydration 0.015 15% 116,666 $5,600,412 Dragon Mountain Gold (ASX:DMG) surged after revealing that it has repaid its October 2024 convertible loan and interest in full, using funds from a new loan provided by an unrelated major shareholder. The move clears the slate and gives DMG more flexibility for future capital raising, as well as assessing new or existing project opportunities. Aurora Energy Metals (ASX:1AE) says Eagle Energy Metals, which holds an option over its Aurora Uranium Project (AUP) in Oregon, is planning to list on the Nasdaq via a SPAC merger with Spring Valley Acquisition Corp. II. If the deal goes through, Aurora will receive US$16 million in Eagle shares, with more to come via milestones and a 1% royalty on future uranium production. Locksley Resources (ASX:LKY) has locked in a heavily oversubscribed $5.3 million raise at $0.095 a share, with strong backing from institutional investors led by Tribeca Investment Partners. The fresh funds will go into drilling high-grade antimony and rare earths at its Mojave project in California, progressing downstream processing in the US. LKY says the raise is a big vote of confidence in its US critical minerals strategy, with more than a dozen new institutions joining the register. Settlement is expected around August 6, with the raise split across two tranches – one already approved, and one pending shareholder tick. ASX SMALL CAP LOSERS Here are the worst performing ASX small cap stocks for August 1 : Code Name Price % Change Volume Market Cap PAB Patrys Limited 0.002 -25% 74,887 $4,731,620 ROG Red Sky Energy. 0.003 -25% 3,106,371 $21,688,909 SYR Syrah Resources 0.275 -24% 12,731,271 $376,567,220 SPX Spenda Limited 0.006 -20% 32 $34,614,116 1TT Thrive Tribe Tech 0.008 -20% 153,010 $1,015,864 GGE Grand Gulf Energy 0.002 -20% 21,282,858 $7,051,062 KNG Kingsland Minerals 0.105 -19% 127,677 $9,432,918 OKJ Oakajee Corp Ltd 0.048 -17% 349,874 $5,303,870 ALM Alma Metals Ltd 0.005 -17% 1,985,774 $11,104,423 ID8 Identitii Limited 0.005 -17% 890,791 $4,668,081 VEN Vintage Energy 0.005 -17% 2,587,531 $12,521,482 LSR Lodestar Minerals 0.016 -16% 728,056 $7,554,219 AIV Activex Limited 0.011 -15% 383,554 $2,801,534 BDM Burgundy D Mines Ltd 0.028 -15% 1,505,337 $46,903,965 YRL Yandal Resources 0.115 -15% 775,878 $41,746,723 GTR Gti Energy Ltd 0.003 -14% 6,150,000 $13,029,292 PLC Premier1 Lithium Ltd 0.006 -14% 330,372 $2,576,424 USL Unico Silver Limited 0.340 -13% 3,032,364 $170,798,064 OD6 Od6Metalsltd 0.021 -13% 577,267 $3,851,231 TX3 Trinex Minerals Ltd 0.110 -12% 516,223 $5,835,180 BEO Beonic Ltd 0.265 -12% 30,000 $21,258,302 MVP Medical Developments 0.540 -11% 71,639 $68,721,578 IN CASE YOU MISSED IT Pure Hydrogen (ASX:PH2) looks to focus on battery electric and hydrogen fuel cell vehicles along with hydrogen equipment, proposing a name change to Pure One. LAST ORDERS DY6 Metals (ASX:DY6) has welcomed Dr Moses Ndasi as in-country manager for Cameroon, bringing more than 20 years' experience in minerals and mining throughout Africa with him. DY6 has also promoted Troth Saindi to exploration manager for Africa, Geoffrey Banda to project geologist, Africa, and Corné Coetser will transition to senior exploration geologist. HyTerra (ASX:HYT) has drilled the McCoy 1 well at the Nemaha hydrogen and helium project in Kansas to a total depth of 5562 feet, on time, within budget, with no safety incidents. McCoy 1 will be converted to an appraisal well over the coming days with a workover rig to proactively monitor the well and evaluate flow test viability. Arika Resources (ASX:ARI) has tapped geologist Steve Vallance as technical director, leveraging his 35 years' experience in gold and nickel sulphide deposits. He most recently served as chief exploration geologist for Jubilee Mines, where he co-led discoveries that eventually led to a $3.3b acquisition by Xstrata Nickel. Star Minerals (ASX:SMS) has advanced four separate permitting studies to the final draft stage, preparing to submit formal applications for flora and fauna, subterranean fauna, and hydrogeology and hydrology assessments and a geological and geotechnical report. With only a few permits left to obtain, SMS says its mining approval application is nearing completion. At Stockhead, we tell it like it is. While DY6 Metals, HyTerra, Arika Resources and Star Minerals are Stockhead advertisers, they did not sponsor this article.
News.com.au
7 hours ago
- News.com.au
What are all these microplastics doing to our brains?
Tiny shards of plastic called microplastics have been detected accumulating in human brains, but there is not yet enough evidence to say whether this is doing us harm, experts have said. These mostly invisible pieces of plastic have been found everywhere from the top of mountains to the bottom of oceans, in the air we breathe and the food we eat. They have also been discovered riddled throughout human bodies, inside lungs, hearts, placentas and even crossing the blood-brain barrier. The increasing ubiquity of microplastics has become a key issue in efforts to hammer out the world's first plastic pollution treaty, with the latest round of UN talks being held in Geneva next week. The effects that microplastics and even smaller nanoplastics have on human health is not yet fully understood, but researchers have been working to find out more in this relatively new field. The most prominent study looking at microplastics in brains was published in the journal Nature Medicine in February. The scientists tested brain tissue from 28 people who died in 2016 and 24 who died last year in the US state of New Mexico, finding that the amount of microplastics in the samples increased over time. The study made headlines around the world when the lead researcher, US toxicologist Matthew Campen, told the media that they detected the equivalent of a plastic spoon's worth of microplastics in the brains. Campen also told Nature that he estimated the researchers could isolate around 10 grammes of plastic from a donated human brain -- comparing that amount to an unused crayon. - Speculation 'far beyond the evidence' - But other researchers have since urged caution about the small study. "While this is an interesting finding, it should be interpreted cautiously pending independent verification," toxicologist Theodore Henry of Scotland's Heriot-Watt University told AFP. "Currently, the speculation about the potential effects of plastic particles on health go far beyond the evidence," he added. Oliver Jones, a chemistry professor at Australia's RMIT University, told AFP there was "not enough data to make firm conclusions on the occurrence of microplastics in New Mexico, let alone globally". He also found it "rather unlikely" that brains could contain more microplastics than has been found in raw sewage -- as the researchers had estimated. Jones pointed out the people in the study were perfectly healthy before they died, and that the researchers acknowledged there was not enough data to show that the microplastics caused harm. "If (and it is a big if in my view) there are microplastics in our brains, there is as yet no evidence of harm," Jones added. The study also contained duplicated images, the neuroscience news website The Transmitter has reported, though experts said this did not affect its main findings. - 'Cannot wait for complete data' - Most of the research into the effects microplastics have on health has been observational, which means it cannot establish cause and effect. One such study, published in the New England Journal of Medicine last year, found that microplastics building up in blood vessels was linked to an increased risk of heart attack, stroke and death in patients with a disease that clogs arteries. There have also been experiments carried out on mice, including a study in Science Advances in January which detected microplastics in their brains. The Chinese researchers said that microplastics can cause rare blood clots in the brains of mice by obstructing cells -- while emphasising that the small mammals are very different to humans. A review by the World Health Organization in 2022 found that the "evidence is insufficient to determine risks to human health" from microplastics. However many health experts have cited the precautionary principle, saying the potential threat microplastics could pose requires action. A report on the health risks of microplastics by the Barcelona Institute for Global Health published this week ahead of the treaty talks said that "policy decisions cannot wait for complete data". "By acting now to limit exposure, improve risk assessment methodologies, and prioritise vulnerable populations, we can address this pressing issue before it escalates into a broader public health crisis," it added. The amount of plastic the world produces has doubled since 2000 -- and is expected to triple from current rates by 2060.
